Mercury Pharma joins September pipe
The buyout of UK pharmaceutical company Mercury Pharma is set to bring more supply to the leveraged loan market, with new owner Cinven working with several banks — including sell-side adviser Jefferies — on launching an all-senior financing to syndication in September.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
